SEC Info - YIELD10 Bioscience, Inc. - ‘10-Q’ for 9/30/22

SEC Info℠

Home

Help

Please Sign In

YIELD10 Bioscience, Inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.CAL’

On: Monday, 11/14/22, at 4:14pm ET · For: 9/30/22 · Accession #: 1121702-22-49 · File #: 1-33133

  As Of               Filer                 Filing    For·On·As Docs:Size

11/14/22  YIELD10 Bioscience, Inc.          10-Q        9/30/22   60:4.8M

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.02M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
10: R1          Cover                                               HTML     69K 
11: R2          Condensed Consolidated Statements of Operations     HTML     85K 
                Unaudited                                                        
12: R3          Condensed Consolidated Balance Sheets Unaudited     HTML    112K 
13: R4          Condensed Consolidated Balance Sheets               HTML     35K 
                (Parenthetical)                                                  
14: R5          Condensed Consolidated Statements of Comprehensive  HTML     44K 
                Loss Unaudited                                                   
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     89K 
                Unaudited                                                        
16: R7          Condensed Consolidated Statements of Stockholders'  HTML     81K 
                Equity                                                           
17: R8          Accounting Policies                                 HTML     51K 
18: R9          Nature of Business and Basis of Presentation        HTML     32K 
19: R10         Basic and Diluted Net Loss Per Share                HTML     28K 
20: R11         Investments                                         HTML     37K 
21: R12         Fair Value Measurements                             HTML     50K 
22: R13         Accrued Expenses                                    HTML     27K 
23: R14         Stock-Based Compensation                            HTML     37K 
24: R15         Leases                                              HTML     46K 
25: R16         Commitments and Contingencies                       HTML     27K 
26: R17         License Agreements                                  HTML     21K 
27: R18         Geographic Information                              HTML     42K 
28: R19         Capital Stock and Warrants                          HTML     42K 
29: R20         Accounting Policies (Policies)                      HTML     93K 
30: R21         Accounting Policies (Tables)                        HTML     37K 
31: R22         Basic and Diluted Net Loss Per Share (Tables)       HTML     26K 
32: R23         Investments (Tables)                                HTML     36K 
33: R24         Fair Value Measurements (Tables)                    HTML     47K 
34: R25         Accrued Expenses (Tables)                           HTML     26K 
35: R26         Stock-Based Compensation (Tables)                   HTML     35K 
36: R27         Leases (Tables)                                     HTML     44K 
37: R28         Geographic Information (Tables)                     HTML     39K 
38: R29         Capital Stock and Warrants (Tables)                 HTML     43K 
39: R30         ACCOUNTING POLICIES - Additional Information        HTML     35K 
                (Details)                                                        
40: R31         ACCOUNTING POLICIES - Schedule of Cash And          HTML     27K 
                Restricted Cash (Details)                                        
41: R32         Nature of Business and Basis of Presentation        HTML     20K 
                (Details)                                                        
42: R33         Basic and Diluted Net Loss Per Share (Details)      HTML     27K 
43: R34         Investments (Details)                               HTML     30K 
44: R35         FAIR VALUE MEASUREMENTS - Assets and Liabilities    HTML     45K 
                Measured at Fair Value on a Recurring Basis                      
                (Details)                                                        
45: R36         Accrued Expenses (Details)                          HTML     29K 
46: R37         Stock-Based Compensation (Details)                  HTML     82K 
47: R38         Stock-Based Compensation - RSU Activity (Details)   HTML     28K 
48: R39         LEASES - Narrative (Details)                        HTML     31K 
49: R40         LEASES - Maturity Analysis of Lease Liabilities     HTML     38K 
                (Details)                                                        
50: R41         LEASES - Quantitative Disclosure of Lease Costs     HTML     33K 
                (Details)                                                        
51: R42         Commitments and Contingencies (Details)             HTML     32K 
52: R43         Geographic Information (Details)                    HTML     31K 
53: R44         CAPITAL STOCK AND WARRANTS - Narrative (Details)    HTML     39K 
54: R45         CAPITAL STOCK AND WARRANTS - Schedule Of Warrants   HTML     34K 
                Issuance (Details)                                               
55: R46         CAPITAL STOCK AND WARRANTS - Schedule of Common     HTML     25K 
                Stock Reserved For Future Issuance (Details)                     
58: XML         IDEA XML File -- Filing Summary                      XML    103K 
56: XML         XBRL Instance -- yten-20220930_htm                   XML   1.11M 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K 
 6: EX-101.CAL  XBRL Calculations -- yten-20220930_cal               XML    135K 
 7: EX-101.DEF  XBRL Definitions -- yten-20220930_def                XML    311K 
 8: EX-101.LAB  XBRL Labels -- yten-20220930_lab                     XML   1.05M 
 9: EX-101.PRE  XBRL Presentations -- yten-20220930_pre              XML    584K 
 5: EX-101.SCH  XBRL Schema -- yten-20220930                         XSD     96K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              296±   448K 
60: ZIP         XBRL Zipped Folder -- 0001121702-22-000049-xbrl      Zip    259K

‘EX-101.CAL’ — XBRL Calculations — yten-20220930_cal

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" xlink:type="simple" xlink:href="yten-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_68bef1bf-8e21-4783-abdd-6486dd31008a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_CostOfRevenueResearchAndDevelopmentExpenses_8be220d9-f3c2-4576-9c22-4cb1f4327b53" xlink:href="yten-20220930.xsd#yten_CostOfRevenueResearchAndDevelopmentExpenses"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_68bef1bf-8e21-4783-abdd-6486dd31008a" xlink:to="loc_yten_CostOfRevenueResearchAndDevelopmentExpenses_8be220d9-f3c2-4576-9c22-4cb1f4327b53" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ca1e0e52-3e3a-4c6c-b465-3941e86e62d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_68bef1bf-8e21-4783-abdd-6486dd31008a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ca1e0e52-3e3a-4c6c-b465-3941e86e62d2" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1ebf6572-b61b-48b9-98ac-f7e805c13540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_47e180ab-cb10-4a3c-81fa-e4108cbf15e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1ebf6572-b61b-48b9-98ac-f7e805c13540" xlink:to="loc_us-gaap_CostsAndExpenses_47e180ab-cb10-4a3c-81fa-e4108cbf15e1" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9f1ba661-fcab-4988-a5d5-4cf6d8fbabdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1ebf6572-b61b-48b9-98ac-f7e805c13540" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9f1ba661-fcab-4988-a5d5-4cf6d8fbabdf" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6fa6672e-838b-4f0e-ba1b-1826c9c33842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_GainOnRelatedPartyInvestment_6c78ec1e-42a5-4728-88a6-3ddaf526f2fe" xlink:href="yten-20220930.xsd#yten_GainOnRelatedPartyInvestment"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_6fa6672e-838b-4f0e-ba1b-1826c9c33842" xlink:to="loc_yten_GainOnRelatedPartyInvestment_6c78ec1e-42a5-4728-88a6-3ddaf526f2fe" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1fa91fa2-5623-4060-b59b-85c47909e908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_6fa6672e-838b-4f0e-ba1b-1826c9c33842" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1fa91fa2-5623-4060-b59b-85c47909e908" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ddbbe1c-a04b-4725-afbf-fe951a9eefcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_659aa980-07e8-4429-886c-0c0f5635eed7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ddbbe1c-a04b-4725-afbf-fe951a9eefcb" xlink:to="loc_us-gaap_OperatingIncomeLoss_659aa980-07e8-4429-886c-0c0f5635eed7" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a4fe3610-6dfe-4c0d-a7b3-bc598fc9b578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ddbbe1c-a04b-4725-afbf-fe951a9eefcb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a4fe3610-6dfe-4c0d-a7b3-bc598fc9b578" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ce96bb2a-6374-45e9-ac08-21f8a0d99e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_448d7e90-d803-4edf-9348-f6ce8dcef5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ce96bb2a-6374-45e9-ac08-21f8a0d99e00" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_448d7e90-d803-4edf-9348-f6ce8dcef5ed" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fb117dba-4fa0-46e3-9f89-324773207ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>

<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ce96bb2a-6374-45e9-ac08-21f8a0d99e00" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fb117dba-4fa0-46e3-9f89-324773207ed3" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="yten-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_79f7e453-1410-4ced-be89-5719809cc41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00f7bc85-9531-4470-a15c-8e9e17b3fbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_79f7e453-1410-4ced-be89-5719809cc41e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_00f7bc85-9531-4470-a15c-8e9e17b3fbd6" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_fd087df6-f188-41e7-a7d3-237efe85fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_79f7e453-1410-4ced-be89-5719809cc41e" xlink:to="loc_us-gaap_ShortTermInvestments_fd087df6-f188-41e7-a7d3-237efe85fd14" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_18849467-7ebd-49d2-aa9f-c0c0964e5731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_79f7e453-1410-4ced-be89-5719809cc41e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_18849467-7ebd-49d2-aa9f-c0c0964e5731" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_8e949c28-0192-4b5e-ae39-e6bb90d9054f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_79f7e453-1410-4ced-be89-5719809cc41e" xlink:to="loc_us-gaap_UnbilledContractsReceivable_8e949c28-0192-4b5e-ae39-e6bb90d9054f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4dfceccd-3770-4f47-84d3-6fa6e3397285" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_79f7e453-1410-4ced-be89-5719809cc41e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4dfceccd-3770-4f47-84d3-6fa6e3397285" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_247ba7ca-cc92-4215-8321-d5e4e0081430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1b9d82cd-9526-40a0-a032-41c76fea8747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_247ba7ca-cc92-4215-8321-d5e4e0081430" xlink:to="loc_us-gaap_Liabilities_1b9d82cd-9526-40a0-a032-41c76fea8747" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3db9e000-0a73-4ced-ba2c-043fbcf2eb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_247ba7ca-cc92-4215-8321-d5e4e0081430" xlink:to="loc_us-gaap_StockholdersEquity_3db9e000-0a73-4ced-ba2c-043fbcf2eb2d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b8275ebe-3546-4c69-b2c2-4b3191a9299e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_247ba7ca-cc92-4215-8321-d5e4e0081430" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b8275ebe-3546-4c69-b2c2-4b3191a9299e" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_68b64307-bf0b-494a-97e8-f2f3399476b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b03096ad-62f9-455f-b813-25c2239ee856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68b64307-bf0b-494a-97e8-f2f3399476b8" xlink:to="loc_us-gaap_AssetsCurrent_b03096ad-62f9-455f-b813-25c2239ee856" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7ed7a991-c8c0-43b4-9a55-61fb59627049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68b64307-bf0b-494a-97e8-f2f3399476b8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7ed7a991-c8c0-43b4-9a55-61fb59627049" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_b89e39ee-d927-4c46-bec5-c750fd2383da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68b64307-bf0b-494a-97e8-f2f3399476b8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_b89e39ee-d927-4c46-bec5-c750fd2383da" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_95a01c3e-0122-4ba6-b88c-df4ed0e04ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68b64307-bf0b-494a-97e8-f2f3399476b8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_95a01c3e-0122-4ba6-b88c-df4ed0e04ba5" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c33d8328-b8ad-4d7a-aa69-5bd1381332b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68b64307-bf0b-494a-97e8-f2f3399476b8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c33d8328-b8ad-4d7a-aa69-5bd1381332b0" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fef45dfe-3c81-4619-bbbb-7218412f8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c897e444-87dd-4072-b4d6-7182315a6c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fef45dfe-3c81-4619-bbbb-7218412f8e21" xlink:to="loc_us-gaap_CommonStockValue_c897e444-87dd-4072-b4d6-7182315a6c0d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c80bfbac-2ac4-4912-b573-1269e7d9299c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fef45dfe-3c81-4619-bbbb-7218412f8e21" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c80bfbac-2ac4-4912-b573-1269e7d9299c" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_082646cc-4aa6-4ea8-8ad0-bdbd614ec326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fef45dfe-3c81-4619-bbbb-7218412f8e21" xlink:to="loc_us-gaap_PreferredStockValue_082646cc-4aa6-4ea8-8ad0-bdbd614ec326" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5037e10b-265d-4e3b-98c5-a13e809ce31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fef45dfe-3c81-4619-bbbb-7218412f8e21" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5037e10b-265d-4e3b-98c5-a13e809ce31b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4c9018fe-fba1-46bf-84ff-23ffa36fc71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fef45dfe-3c81-4619-bbbb-7218412f8e21" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4c9018fe-fba1-46bf-84ff-23ffa36fc71d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1f270d64-e369-423c-9fd3-01db854f5116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_aab4ae6f-21bb-4a4f-9145-b17dac38a141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f270d64-e369-423c-9fd3-01db854f5116" xlink:to="loc_us-gaap_AccountsPayableCurrent_aab4ae6f-21bb-4a4f-9145-b17dac38a141" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0a1167f3-7627-43bd-b726-46e55ee83e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f270d64-e369-423c-9fd3-01db854f5116" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0a1167f3-7627-43bd-b726-46e55ee83e7c" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_211ce7cc-6faa-4da9-92e4-b1578072ac67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f270d64-e369-423c-9fd3-01db854f5116" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_211ce7cc-6faa-4da9-92e4-b1578072ac67" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9c9c5572-4203-4007-b002-132095fd5b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9c9d64fc-bd7f-41dc-8c09-7d461902d667" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9c9c5572-4203-4007-b002-132095fd5b6c" xlink:to="loc_us-gaap_LiabilitiesCurrent_9c9d64fc-bd7f-41dc-8c09-7d461902d667" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8ca6bb0b-f8eb-4568-9938-4aaf765d2efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9c9c5572-4203-4007-b002-132095fd5b6c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8ca6bb0b-f8eb-4568-9938-4aaf765d2efd" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED" xlink:type="simple" xlink:href="yten-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUNAUDITED" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1c82edfa-1055-42ea-ab4e-6b10476ccb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8eb34d99-5049-4672-b69d-a067416738c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1c82edfa-1055-42ea-ab4e-6b10476ccb5e" xlink:to="loc_us-gaap_NetIncomeLoss_8eb34d99-5049-4672-b69d-a067416738c5" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f92edd12-d508-4253-9c65-df0f387d3d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1c82edfa-1055-42ea-ab4e-6b10476ccb5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f92edd12-d508-4253-9c65-df0f387d3d3f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2dfb3a22-2ddc-434d-b0ce-0452fc43bbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e475bc63-2b50-498e-a866-0903fb7913e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2dfb3a22-2ddc-434d-b0ce-0452fc43bbbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e475bc63-2b50-498e-a866-0903fb7913e7" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0d93d65a-be44-42fb-8c5c-118c607a1cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2dfb3a22-2ddc-434d-b0ce-0452fc43bbbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0d93d65a-be44-42fb-8c5c-118c607a1cad" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="yten-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0532d3a3-a34d-4433-ad73-c63ac14786d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6bbb6280-4683-4846-b13a-30ea67168ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0532d3a3-a34d-4433-ad73-c63ac14786d5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6bbb6280-4683-4846-b13a-30ea67168ccf" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6bd881ac-3324-410b-ae1a-64256eb240a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0532d3a3-a34d-4433-ad73-c63ac14786d5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6bd881ac-3324-410b-ae1a-64256eb240a5" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4917f5bf-2843-44c9-bc93-14d681c16406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0532d3a3-a34d-4433-ad73-c63ac14786d5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4917f5bf-2843-44c9-bc93-14d681c16406" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc138ecb-d95d-44e6-93fb-8dbacc5f3b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0532d3a3-a34d-4433-ad73-c63ac14786d5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc138ecb-d95d-44e6-93fb-8dbacc5f3b1c" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c6e78e3-e1f3-4cc7-ba42-05ac665ce0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_NetIncomeLoss_3c6e78e3-e1f3-4cc7-ba42-05ac665ce0d5" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_430c8a6f-1cf1-423d-bb82-fbad6ad66dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_430c8a6f-1cf1-423d-bb82-fbad6ad66dda" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_ChargeForCompanyCommonStockMatch_4e8bc0e7-c96c-4fab-b06e-af95ca2fafdf" xlink:href="yten-20220930.xsd#yten_ChargeForCompanyCommonStockMatch"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_yten_ChargeForCompanyCommonStockMatch_4e8bc0e7-c96c-4fab-b06e-af95ca2fafdf" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cf0064b8-0923-4a60-b351-40c752221dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_ShareBasedCompensation_cf0064b8-0923-4a60-b351-40c752221dff" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_NoncashLeaseExpenseIncome_2c9a2702-6ded-40e0-964d-162f42bbd863" xlink:href="yten-20220930.xsd#yten_NoncashLeaseExpenseIncome"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_yten_NoncashLeaseExpenseIncome_2c9a2702-6ded-40e0-964d-162f42bbd863" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9dc4c293-5456-4fbb-a105-dd18c22632da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>

<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9dc4c293-5456-4fbb-a105-dd18c22632da" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_07457018-800b-4b98-bec3-68be03fc17dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>

<link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_07457018-800b-4b98-bec3-68be03fc17dd" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_430ca5f6-67cb-4681-a0a8-361164ea0436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>

<link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_430ca5f6-67cb-4681-a0a8-361164ea0436" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_303552f9-d18c-4aba-833f-3a7672b76a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>

<link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_303552f9-d18c-4aba-833f-3a7672b76a94" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b5d33f4c-7db1-4155-bddf-7fcb6c7a964d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>

<link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b5d33f4c-7db1-4155-bddf-7fcb6c7a964d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_53fbec29-164f-40a0-949e-23f5ac5ca32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>

<link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_53fbec29-164f-40a0-949e-23f5ac5ca32b" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_IncreaseDecreaseInLeaseLiabilities_a48bd8dd-9561-4d5d-b882-3a017f787400" xlink:href="yten-20220930.xsd#yten_IncreaseDecreaseInLeaseLiabilities"/>

<link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_270b81a0-7008-424d-bf85-cfdb85a24fc3" xlink:to="loc_yten_IncreaseDecreaseInLeaseLiabilities_a48bd8dd-9561-4d5d-b882-3a017f787400" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_580676a7-1d35-4c6c-89fa-ea2622f9fe0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_551cda86-551b-4154-89c6-4a23f6576c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_580676a7-1d35-4c6c-89fa-ea2622f9fe0e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_551cda86-551b-4154-89c6-4a23f6576c4d" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_16fe571f-06e4-446a-9df9-a23383d88d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>

<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_580676a7-1d35-4c6c-89fa-ea2622f9fe0e" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_16fe571f-06e4-446a-9df9-a23383d88d74" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7101e911-07c0-4c6b-96f6-bf8cddcc6539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_580676a7-1d35-4c6c-89fa-ea2622f9fe0e" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_7101e911-07c0-4c6b-96f6-bf8cddcc6539" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2321076f-ce6e-4cda-9a0d-aaee82b1b071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_ProceedsFromWarrantExercisesNet_2ef1436d-f129-43a8-8133-b7ad3776f4ca" xlink:href="yten-20220930.xsd#yten_ProceedsFromWarrantExercisesNet"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2321076f-ce6e-4cda-9a0d-aaee82b1b071" xlink:to="loc_yten_ProceedsFromWarrantExercisesNet_2ef1436d-f129-43a8-8133-b7ad3776f4ca" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_7d5d659f-744c-46cf-83df-0373eb7b6d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2321076f-ce6e-4cda-9a0d-aaee82b1b071" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_7d5d659f-744c-46cf-83df-0373eb7b6d51" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6e1984da-9406-4eb1-aaa8-7f2698cd797b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>

<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2321076f-ce6e-4cda-9a0d-aaee82b1b071" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6e1984da-9406-4eb1-aaa8-7f2698cd797b" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails" xlink:type="simple" xlink:href="yten-20220930.xsd#ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/ACCOUNTINGPOLICIESScheduleofCashAndRestrictedCashDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54267f12-c78c-4943-8d7e-9d4f7d01bd98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_456a8fac-352f-4529-aeba-df2f574567de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54267f12-c78c-4943-8d7e-9d4f7d01bd98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_456a8fac-352f-4529-aeba-df2f574567de" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_e198065c-a9bb-4d65-b868-cdec7be6a044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_54267f12-c78c-4943-8d7e-9d4f7d01bd98" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_e198065c-a9bb-4d65-b868-cdec7be6a044" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/INVESTMENTSDetails" xlink:type="simple" xlink:href="yten-20220930.xsd#INVESTMENTSDetails"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/INVESTMENTSDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_282586ab-f9f3-478b-aadb-9a2b76ab00b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9202ce08-1ebf-4649-a56a-439bc121c4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>

<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_282586ab-f9f3-478b-aadb-9a2b76ab00b7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9202ce08-1ebf-4649-a56a-439bc121c4b7" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_44dba7b4-cb3c-441e-9a4a-620dc05bb7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_282586ab-f9f3-478b-aadb-9a2b76ab00b7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_44dba7b4-cb3c-441e-9a4a-620dc05bb7ed" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_120e0489-ec34-4fb7-b5ca-ce0b305af4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_282586ab-f9f3-478b-aadb-9a2b76ab00b7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_120e0489-ec34-4fb7-b5ca-ce0b305af4bd" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="yten-20220930.xsd#FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/FAIRVALUEMEASUREMENTSAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6b0142a8-efdb-47dd-9091-6c7294b2e7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6b98a702-4040-4456-b174-174f19d1cd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6b0142a8-efdb-47dd-9091-6c7294b2e7aa" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6b98a702-4040-4456-b174-174f19d1cd8e" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b03d57df-8cdf-4434-b50d-2630a1b7a836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6b0142a8-efdb-47dd-9091-6c7294b2e7aa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b03d57df-8cdf-4434-b50d-2630a1b7a836" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="yten-20220930.xsd#ACCRUEDEXPENSESDetails"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_088b121f-8ae9-4f02-af84-39906f2bf99b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_89a48db4-3665-4e47-ad4c-6b72c0f541ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_088b121f-8ae9-4f02-af84-39906f2bf99b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_89a48db4-3665-4e47-ad4c-6b72c0f541ef" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_20fb6a87-f7a6-4626-8f3d-6d924c9525b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_088b121f-8ae9-4f02-af84-39906f2bf99b" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_20fb6a87-f7a6-4626-8f3d-6d924c9525b4" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a30031a0-2a2f-46b3-b8ad-3b425fedaba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_088b121f-8ae9-4f02-af84-39906f2bf99b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a30031a0-2a2f-46b3-b8ad-3b425fedaba2" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_AccruedLeaseCost_15b3e7b9-cd43-468a-b3bf-260e412b4266" xlink:href="yten-20220930.xsd#yten_AccruedLeaseCost"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_088b121f-8ae9-4f02-af84-39906f2bf99b" xlink:to="loc_yten_AccruedLeaseCost_15b3e7b9-cd43-468a-b3bf-260e412b4266" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_AccruedFieldTrialsAndRelatedExpensesCurrent_b1e5a4a9-7725-4073-a21e-c3f379d54f86" xlink:href="yten-20220930.xsd#yten_AccruedFieldTrialsAndRelatedExpensesCurrent"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_088b121f-8ae9-4f02-af84-39906f2bf99b" xlink:to="loc_yten_AccruedFieldTrialsAndRelatedExpensesCurrent_b1e5a4a9-7725-4073-a21e-c3f379d54f86" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="yten-20220930.xsd#LEASESMaturityAnalysisofLeaseLiabilitiesDetails"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/LEASESMaturityAnalysisofLeaseLiabilitiesDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eee86c37-ea2e-4190-8c07-6bed76e360fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_57a85571-6f51-4665-8caa-52202f50d8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eee86c37-ea2e-4190-8c07-6bed76e360fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_57a85571-6f51-4665-8caa-52202f50d8d6" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b7bbea5c-aff6-4988-be45-95181ed94a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eee86c37-ea2e-4190-8c07-6bed76e360fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b7bbea5c-aff6-4988-be45-95181ed94a6e" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_51d52ac0-2ed0-4965-ba6e-11e281c8207a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>

<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eee86c37-ea2e-4190-8c07-6bed76e360fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_51d52ac0-2ed0-4965-ba6e-11e281c8207a" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8ee3d2a7-9b63-48d6-a464-e1f5105d4246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>

<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eee86c37-ea2e-4190-8c07-6bed76e360fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8ee3d2a7-9b63-48d6-a464-e1f5105d4246" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8cf1431b-9658-4c78-8019-9839f3dd26fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>

<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eee86c37-ea2e-4190-8c07-6bed76e360fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8cf1431b-9658-4c78-8019-9839f3dd26fd" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_84f842cd-d42b-4d05-a40a-11f7b61d92c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5a04acc4-a87e-42dc-9c41-9c4ccc8d6afb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_84f842cd-d42b-4d05-a40a-11f7b61d92c0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5a04acc4-a87e-42dc-9c41-9c4ccc8d6afb" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_yten_OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet_24e30f61-0283-4fa4-87be-307444e522a8" xlink:href="yten-20220930.xsd#yten_OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_84f842cd-d42b-4d05-a40a-11f7b61d92c0" xlink:to="loc_yten_OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet_24e30f61-0283-4fa4-87be-307444e522a8" xlink:type="arc"/>

</link:calculationLink>

<link:roleRef roleURI="http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails" xlink:type="simple" xlink:href="yten-20220930.xsd#LEASESQuantitativeDisclosureofLeaseCostsDetails"/>

<link:calculationLink xlink:role="http://www.yield10bio.com/role/LEASESQuantitativeDisclosureofLeaseCostsDetails" xlink:type="extended">

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_edc56d51-45c0-4424-9875-a74dc3cf0eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_138bc975-3976-4a9f-9c2e-33e85bfe84d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>

<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_edc56d51-45c0-4424-9875-a74dc3cf0eee" xlink:to="loc_us-gaap_OperatingLeaseCost_138bc975-3976-4a9f-9c2e-33e85bfe84d8" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_7ca8a094-4402-45da-bbe4-56dc8da5674f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>

<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_edc56d51-45c0-4424-9875-a74dc3cf0eee" xlink:to="loc_us-gaap_ShortTermLeaseCost_7ca8a094-4402-45da-bbe4-56dc8da5674f" xlink:type="arc"/>

<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_00b746a9-d16b-4d30-9527-b71ecbaf5161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>

<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_edc56d51-45c0-4424-9875-a74dc3cf0eee" xlink:to="loc_us-gaap_SubleaseIncome_00b746a9-d16b-4d30-9527-b71ecbaf5161" xlink:type="arc"/>

</link:calculationLink>

</link:linkbase>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/24/23  YIELD10 Bioscience, Inc.          424B5                  1:587K

2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/11/22  YIELD10 Bioscience, Inc.          10-Q        3/31/22   59:4.5M
 3/25/22  YIELD10 Bioscience, Inc.          10-K       12/31/21   83:9.4M

↑Top

Filing Submission 0001121702-22-000049 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

YIELD10 Bioscience, Inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.CAL’

On: Monday, 11/14/22, at 4:14pm ET · For: 9/30/22 · Accession #: 1121702-22-49 · File #: 1-33133

Quarterly Report — Form 10-QFiling Table of Contents

‘EX-101.CAL’ — XBRL Calculations — yten-20220930_cal

This Exhibit is an XBRL XML File.

1 Subsequent Filing that References this Filing

2 Previous Filings that this Filing References

Quarterly Report — Form 10-Q

Filing Table of Contents